Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.20
+0.06 (0.98%)
Dec 26, 2025, 4:00 PM EST - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $292.85 million as of December 26, 2025. Its market cap has decreased by -16.18% in one year.
Market Cap
292.85M
Enterprise Value
190.84M
1-Year Change
-16.18%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $292.85M, a decrease of -45.60%. That is a compound annual growth rate of -10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 292.85M | -9.85% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |